MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer (Q39613814)

13 September 2017

title

MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer (English)

1 reference

13 September 2017

1 reference

Yi Yang

1

1 reference

13 September 2017

Lei Liu

2

1 reference

13 September 2017

Ying Zhang

3

1 reference

13 September 2017

Hongyu Guan

4

1 reference

13 September 2017

Jueheng Wu

5

1 reference

13 September 2017

Xun Zhu

6

1 reference

13 September 2017

Jie Yuan

7

1 reference

13 September 2017

Mengfeng Li

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

27 March 2014

1 reference

International Journal of Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

135

1 reference

13 September 2017

issue

7

1 reference

13 September 2017

page(s)

1531-1542

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

13 September 2017

cites work

1 reference

21 January 2018

Global cancer statistics

1 reference

Multidisciplinary management of lung cancer

21 January 2018

1 reference

Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.

21 January 2018

1 reference

Treatment of non-small-cell lung cancer with erlotinib or gefitinib

21 January 2018

1 reference

Importance of molecular features of non-small cell lung cancer for choice of treatment

21 January 2018

1 reference

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta

21 January 2018

1 reference

MicroRNAs: critical regulators of development, cellular physiology and malignancy

21 January 2018

1 reference

MicroRNA-503 and the extended microRNA-16 family in angiogenesis

21 January 2018

1 reference

Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.

21 January 2018

1 reference

MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.

21 January 2018

1 reference

MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.

21 January 2018

1 reference

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma

21 January 2018

1 reference

Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis

21 January 2018

1 reference

Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis

21 January 2018

1 reference

MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A.

21 January 2018

1 reference

Systematic validation of predicted microRNAs for cyclin D1

21 January 2018

1 reference

Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell

21 January 2018

1 reference

Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer?

21 January 2018

1 reference

miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation.

21 January 2018

1 reference

MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.

21 January 2018

1 reference

Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells

21 January 2018

1 reference

MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop

21 January 2018

1 reference

Lung cancer in never smokers: a review

21 January 2018

1 reference

21 January 2018

1 reference

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

21 January 2018

1 reference

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance

21 January 2018

1 reference

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

21 January 2018

1 reference

Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells

21 January 2018

1 reference

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a

21 January 2018

1 reference

Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

21 January 2018

1 reference

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors.

21 January 2018

1 reference

Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

21 January 2018

1 reference

Enhanced G2-M arrest by nuclear factor-{kappa}B-dependent p21waf1/cip1 induction

21 January 2018

1 reference

Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition

21 January 2018

1 reference

Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/SJ.LEU.2402641

Identifiers

DOI

10.1002/IJC.28799

1 reference

13 September 2017

1 reference